Inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2006203963 (hide)

Owner Merck & Co., Inc.

Inventors Garbaccio, Robert M.; Steen, Justin T.; Fraley, Mark E.; Brnardic, Edward J.

Agent Spruson & Ferguson

Pub. Number AU-A-2006203963

PCT Pub. Number WO2006/074281

Priority 60/691,694 17.06.05 US; 60/641,721 06.01.05 US

Filing date 5 January 2006

Wipo publication date 13 July 2006

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

Event Publications

28 June 2007 PCT application entered the National Phase

  PCT publication WO2006/074281 Priority application(s): WO2006/074281

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006203965-Drain with occlusion removing structure

2006203957-Method for encoding messages between two devices for transmission over standard online payment networks